Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371200 · ClinicalTrials.gov registry record
Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
A clinical trial, sponsored by Brain Sentinel.
- Completed
- Registry status
- 13
- Enrollment target
NCT02371200 is a clinical trial that has completed, run by Brain Sentinel. The registered enrollment target is 13 participants.
The verdict
NCT02371200 has completed, sponsored by Brain Sentinel.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
Prospective study of an electromyography (EMG) based seizure detection and warning system for detecting generalized tonic-clonic (GTC) seizures.
Interventions
- DEVICE Brain Sentinel Seizure Detection and Warning System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02371200
The ClinicalTrials.gov registry entry for NCT02371200 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brain Sentinel, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brain Sentinel Seizure Detection and Warning System is the first listed.
NCT02371200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02371200 about?
NCT02371200 is a clinical study titled "Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients". Prospective study of an electromyography (EMG) based seizure detection and warning system for detecting generalized tonic-clonic (GTC) seizures.
What is the current status of trial NCT02371200?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-04. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02371200?
The interventions under investigation include: Brain Sentinel Seizure Detection and Warning System (DEVICE).
Who is sponsoring clinical trial NCT02371200?
This trial is sponsored by Brain Sentinel, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.